Treating Tinea Capitis with Unani Formulation: A Case Study of 25-year-old Male Patient

Authors

  • Mohammad Zaki Ahmad PG Scholar, Department of Ilaj Bit Tadbeer, National Institute of Unani Medicine, Bengaluru, Karnataka, India
  • Abdul Nasir Ansari Professor & Head, Department of Ilaj Bit Tadbeer, National Institute of Unani Medicine, Bengaluru, Karnataka, India
  • Musab Ahmad PG Scholar, Department of Moalajat (Medicine), National Institute of Unani Medicine, Bengaluru, Karnataka, India
  • Mohammad Tarik PG Scholar, Department of Moalajat (Medicine), National Institute of Unani Medicine, Bengaluru, Karnataka, India
  • Nazreen Fatma PG Scholar, Department of Moalajat (Medicine), National Institute of Unani Medicine, Bengaluru, Karnataka, India
  • Sawood Ahmad MD, Department of Ilmul Advia, Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

Keywords:

Dermatophytes, Q?b?, Sharbat-i-‘Unn?b, Tinea Capitis.

Abstract

Tinea Capitis is a superficial fungal infection of scalp, mainly caused by dermatophytes Trichophyton tonsurans and Microsporum canis (highly inflammatory) and Microsporum audouinii are second most common cause. It has two types’ viz. endothrix and ectothrix. Tinea Capitis is also known as Ringworm of the scalp and Tinea tonsurans. In Unani System of Medicine Tinea is known as Qūbā, characterized by burning, itching along with roughness and desquamation over skin surface in which scales shed off from the skin. Unani System of Medicine provides a wide range of antifungal drugs. Case presentation: A 25-year-old male patient came to outpatient department of NIUM Hospital, with complaints of itchy and erythematous scalp lesions combined with hair loss for past 6 months. He was suspected of dermatophytosis and mycological analysis of all suspected lesions was performed. Clinical features and KOH scrapping results confirmed tinea capitis. The patient was treated with a Unani Ointment and Sharbat-i-‘Unnāb for 6 weeks. Discussion: Evidence-based treatment of Unani medicine to improve the condition of the patient with Tinea capitis is discussed here. 

Author Biographies

  • Mohammad Zaki Ahmad, PG Scholar, Department of Ilaj Bit Tadbeer, National Institute of Unani Medicine, Bengaluru, Karnataka, India
    Department of Ilaj Bit Tadbeer, PG Scholar
  • Abdul Nasir Ansari, Professor & Head, Department of Ilaj Bit Tadbeer, National Institute of Unani Medicine, Bengaluru, Karnataka, India
    Department of Ilaj Bit Tadbeer, Professor
  • Musab Ahmad, PG Scholar, Department of Moalajat (Medicine), National Institute of Unani Medicine, Bengaluru, Karnataka, India
    Department of Moalajat, PG Scholar
  • Mohammad Tarik, PG Scholar, Department of Moalajat (Medicine), National Institute of Unani Medicine, Bengaluru, Karnataka, India
    Department of Moalajat, PG Scholar
  • Nazreen Fatma, PG Scholar, Department of Moalajat (Medicine), National Institute of Unani Medicine, Bengaluru, Karnataka, India
    Department of Moalajat, PG Scholar
  • Sawood Ahmad, MD, Department of Ilmul Advia, Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

    Department of Ilmul Advia, MD

References

Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;

Karimkhani C, Boyers LN, Prescott L, Welch V, Delamere FM, Nasser M, et al. Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. JAMA Dermatology. 2014;

Fitzpatrick James E., Morelli Joseph G., Dermatology Secrets in Colour. 3rd ed. New Delhi, Elsevier, pp, 253–60.

Sams W., Mitchell, Lynch Peter J., (1996). Principle and Practice of Dermatology. 2nd ed. Singapore, Churchill Livingston, pp, 149–57.

Degreef H. Clinical forms of dermatophytosis (ringworm infection). Mycopathologia. 2008;166,257–265.

Donald A. Jonathan Clinical Infection Diseases. New York: Barcelona Harcourt Publisher Ltd; 1999. 6.1–6.6.

Mandell Gerald L, Bennet john E, Raphael D, (2005). Principles and Practice of Infectious diseases, Vol, 2. 6th ed. Pennsylvania, Elsevier Churchill Livingston, pp, 3051–3059.

McKee Phillip H., Calonje E., Granter Scott R. Pathology of the Skin with Clinical Correlation. Vol-I, 3rd ed. London: Elsevier; 2005. 939–43.

Weitzman, I., Sumberbell, R.C., (1955). The Dermatophytes Clinical Microbiological Reviews, 8, pp. 240–259.

Jamaluddin. Aqsaraee. Vol. I. Mumbai: Naval Kishore; 478–479 p.

Kabeeruddin M, Bayaze Kabeer, vol II, New Delhi: Idara Kitab-ul-Shifa, 118.

Anonymous (1987). Standards of single drugs of Unani Medicine, Central Council for Research in Unani medicine, Ministry of Health & Family Welfare, Government of India, New Delhi, part-II, pp. 201–205.

Munshi G.N., (2007). Makhzan Mufradat wa Murakkabat Almaroof ba Khawaasul Advia CCRIUM, Ministry of Health & Family Welfare, Dept, of AYUSH, Govt, of India, New Delhi, pp. 190, 224.

Mesaik AM, Poh HW, Bin OY, Elawad I, Alsayed B. In vivo anti-inflammatory, anti-bacterial and anti-diarrhoeal activity of Ziziphus Jujuba fruit extract. Open access Macedonian journal of medical sciences. 2018 May 20;6(5):757.

Arndt SK, Clifford SC, Popp M. Ziziphus—a multipurpose fruit tree for arid regions. In Sustainable land use in deserts 2001 (pp. 388–399). Springer, Berlin, Heidelberg.

Mahajan RT, Chopda M. Phyto-Pharmacology of Ziziphus jujuba Mill-A plant review. Pharmacognosy Reviews. 2009 Jul 1;3(6):320.

Allah Rakha Qureshi, DR. Jabdatul Atibba., (1957). Bustanul Mufridat, Hazi Malik Serajuddin and sartajran Qutub Kshmiri paz Lahore, pp. 206, 238, 256.

Hakeem MA, Makhzan-ul-Mufradat-ma-Murakabat-wa-khawasul Advia, Idarah

Taraqqi Urdu Publication, Lucknow, pp. 195, 256, 279.

Ghani, H.N., (2010). Khazainul Advia, Central Council for Research in Unani Medicine, Dept, of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi, Vol. VI, PP. 263–265, 466–469.

Haleem, H.M., (2009). Mufridat-e-Azizi, Central Council for Research in Unani Medicine, New Delhi, pp. 66, 91, 92, & 93.

Downloads

Published

2020-10-22

Issue

Vol. 9 No. 2 (2020)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.